Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer

Oncology Reports

Volumn 14, Issue 1, 2005, Pages 89-92

  Kodama, Junichi ^a   Shinyo, Yasuhiro ^a   Hasengaowa, ^a   Kusumoto, Tomoyuki ^a   Seki, Noriko ^a   Nakamura, Keiichiro ^a   Hongo, Atsushi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Heparan sulfate; Heparanase

Indexed keywords

BETA GLUCURONIDASE; HEPARANASE; MESSENGER RNA; PERLECAN; PROTEOHEPARAN SULFATE;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; BIOSYNTHESIS; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; AGED; BASEMENT MEMBRANE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 24644505928     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bernfield M, Gotte M, Park PW, et al: Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68: 729-777, 1999. (Pubitemid 29449208)
2. Yanagishita M and Hascall VC: Cell surface heparan sulfate proteoglycans. J Biol Chem 267: 9451-9454, 1992.
3. Jiang X and Couchman JR: Perlecan and tumor angiogenesis. J Histochem Cytochem 51: 1393-1410, 2003. (Pubitemid 37444529)
4. Nakajima M, Irimura T, Di Ferrante N and Nicolson GL: Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. J Biol Chem 259: 2283-2290, 1984. (Pubitemid 14190344)
5. Simizu S, Ishida K and Osada H: Heparanase as a molecular target of cancer chemotherapy. Cancer Sci 95: 553-558, 2004. (Pubitemid 39089634)
6. Uno F, Fujiwara T, Takata Y, et al: Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res 61: 7855-7860, 2001. (Pubitemid 33049375)
7. Parish CR, Freeman C, Brown KJ, Francis DJ and Cowden WB: Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59: 3433-3441, 1999. (Pubitemid 29334505)
8. Shinyo Y, Kodarna J, Hongo A, Yoshinouchi M and Hiramatsu U: Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Ann Oncol 14: 1505-1510, 2003. (Pubitemid 37304605)
9. Vlodavsky I, Friedmann Y, Elkin M, et al: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5: 793-802, 1999. (Pubitemid 29318614)
10. Blackhall FH, Merry CLR, Davies EJ and Jayson GC: Heparan sulfate proteoglycans and cancer. Br J Cancer 85: 1094-1098, 2001. (Pubitemid 33052304)
11. Xu X, Quiros RM, Maxhimer JB, et al: Inverse correlation between heparan sulfate composition and heparanase-1 expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Clin Cancer Res 9: 5968-5979, 2003. (Pubitemid 38018083)
12. Reiland J, Sanderson RD, Waguepack M, et al: Heparanase degrade syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 27: 8047-8055, 2004. (Pubitemid 38294693)